

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.73544342 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.73544342 |
| 3 | detection of other organism (GO:0098543) | 4.62598689 |
| 4 | detection of bacterium (GO:0016045) | 4.54712151 |
| 5 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.31297479 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.31049748 |
| 7 | macrophage activation involved in immune response (GO:0002281) | 4.28892568 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 4.22011524 |
| 9 | leukocyte aggregation (GO:0070486) | 4.15197527 |
| 10 | detection of external biotic stimulus (GO:0098581) | 3.80771310 |
| 11 | DNA deamination (GO:0045006) | 3.72065151 |
| 12 | myeloid cell activation involved in immune response (GO:0002275) | 3.64401796 |
| 13 | cellular extravasation (GO:0045123) | 3.61927622 |
| 14 | daunorubicin metabolic process (GO:0044597) | 3.57023620 |
| 15 | polyketide metabolic process (GO:0030638) | 3.57023620 |
| 16 | doxorubicin metabolic process (GO:0044598) | 3.57023620 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55169494 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.49715723 |
| 19 | response to host immune response (GO:0052572) | 3.49715723 |
| 20 | response to peptidoglycan (GO:0032494) | 3.48846318 |
| 21 | negative regulation of phagocytosis (GO:0050765) | 3.48544920 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 3.45654256 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 3.41598281 |
| 24 | detection of biotic stimulus (GO:0009595) | 3.38194658 |
| 25 | leukocyte degranulation (GO:0043299) | 3.36352180 |
| 26 | pyrimidine nucleoside salvage (GO:0043097) | 3.36045020 |
| 27 | pyrimidine-containing compound salvage (GO:0008655) | 3.36045020 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33342620 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.32416061 |
| 30 | neutrophil mediated immunity (GO:0002446) | 3.30909640 |
| 31 | viral transcription (GO:0019083) | 3.28484821 |
| 32 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.23311003 |
| 33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20927832 |
| 34 | microglial cell activation (GO:0001774) | 3.18269354 |
| 35 | B cell mediated immunity (GO:0019724) | 3.16931386 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16394792 |
| 37 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.16336164 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.16125114 |
| 39 | translational termination (GO:0006415) | 3.14366227 |
| 40 | response to host (GO:0075136) | 3.12374281 |
| 41 | response to host defenses (GO:0052200) | 3.12374281 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.12374281 |
| 43 | macrophage activation (GO:0042116) | 3.12111390 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09440367 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08562801 |
| 46 | pentose-phosphate shunt (GO:0006098) | 3.07864175 |
| 47 | response to interferon-beta (GO:0035456) | 3.03992546 |
| 48 | ribosomal small subunit biogenesis (GO:0042274) | 3.03560115 |
| 49 | positive regulation of mast cell activation (GO:0033005) | 2.99433609 |
| 50 | maturation of SSU-rRNA (GO:0030490) | 2.98992676 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 2.97926238 |
| 52 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.97600021 |
| 53 | formation of translation preinitiation complex (GO:0001731) | 2.94285418 |
| 54 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.92447708 |
| 55 | NADPH regeneration (GO:0006740) | 2.92364862 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.91428141 |
| 57 | IMP biosynthetic process (GO:0006188) | 2.88424228 |
| 58 | negative regulation of innate immune response (GO:0045824) | 2.88041208 |
| 59 | regulation of superoxide anion generation (GO:0032928) | 2.85733214 |
| 60 | response to interferon-alpha (GO:0035455) | 2.81951297 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81580444 |
| 62 | regulation of mast cell activation (GO:0033003) | 2.80606918 |
| 63 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.79714795 |
| 64 | nucleoside salvage (GO:0043174) | 2.79031475 |
| 65 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.78532898 |
| 66 | translational elongation (GO:0006414) | 2.78189942 |
| 67 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77339358 |
| 68 | myeloid leukocyte mediated immunity (GO:0002444) | 2.77261290 |
| 69 | DNA strand elongation (GO:0022616) | 2.76964231 |
| 70 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.73912340 |
| 71 | regulation of tolerance induction (GO:0002643) | 2.72739213 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.71534641 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 2.71534641 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 2.71078085 |
| 75 | amino sugar catabolic process (GO:0046348) | 2.70246549 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.69198969 |
| 77 | regulation of gamma-delta T cell activation (GO:0046643) | 2.69070424 |
| 78 | protein targeting to ER (GO:0045047) | 2.68414378 |
| 79 | cotranslational protein targeting to membrane (GO:0006613) | 2.67911397 |
| 80 | telomere maintenance via recombination (GO:0000722) | 2.66549419 |
| 81 | negative regulation of interleukin-6 production (GO:0032715) | 2.66083920 |
| 82 | purine nucleotide salvage (GO:0032261) | 2.62831704 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.62227196 |
| 84 | regulation of T cell tolerance induction (GO:0002664) | 2.60465599 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60362134 |
| 86 | translational initiation (GO:0006413) | 2.60243513 |
| 87 | myeloid leukocyte activation (GO:0002274) | 2.60109031 |
| 88 | pentose metabolic process (GO:0019321) | 2.59528136 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58941690 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.58808796 |
| 91 | nucleotide salvage (GO:0043173) | 2.57891795 |
| 92 | DNA replication initiation (GO:0006270) | 2.57241350 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56531165 |
| 94 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56265190 |
| 95 | cellular response to zinc ion (GO:0071294) | 2.56202964 |
| 96 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.55206644 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.54473479 |
| 98 | IMP metabolic process (GO:0046040) | 2.53945359 |
| 99 | DNA replication checkpoint (GO:0000076) | 2.53321619 |
| 100 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.51655275 |
| 101 | negative regulation of T cell mediated immunity (GO:0002710) | 2.51508119 |
| 102 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.51279482 |
| 103 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.51093099 |
| 104 | regulation of B cell differentiation (GO:0045577) | 2.50828534 |
| 105 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.49847293 |
| 106 | regulation of gene silencing by RNA (GO:0060966) | 2.49391277 |
| 107 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.49391277 |
| 108 | regulation of gene silencing by miRNA (GO:0060964) | 2.49391277 |
| 109 | defense response to protozoan (GO:0042832) | 2.48301680 |
| 110 | pinocytosis (GO:0006907) | 2.47528249 |
| 111 | response to muramyl dipeptide (GO:0032495) | 2.47343371 |
| 112 | protein localization to endoplasmic reticulum (GO:0070972) | 2.47291203 |
| 113 | respiratory burst (GO:0045730) | 2.46787668 |
| 114 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.46572249 |
| 115 | ribosomal large subunit biogenesis (GO:0042273) | 2.45298701 |
| 116 | superoxide anion generation (GO:0042554) | 2.44225515 |
| 117 | regulation of RIG-I signaling pathway (GO:0039535) | 2.43917218 |
| 118 | viral life cycle (GO:0019058) | 2.42807502 |
| 119 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.42453032 |
| 120 | positive regulation of interferon-alpha production (GO:0032727) | 2.42390230 |
| 121 | reactive oxygen species biosynthetic process (GO:1903409) | 2.41398802 |
| 122 | negative regulation of interleukin-12 production (GO:0032695) | 2.40641561 |
| 123 | interferon-gamma secretion (GO:0072643) | 2.40301678 |
| 124 | response to protozoan (GO:0001562) | 2.37711462 |
| 125 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.37161616 |
| 126 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.35946386 |
| 127 | mitotic recombination (GO:0006312) | 2.35140394 |
| 128 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.34827621 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.33178292 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.33178292 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33178292 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.33178292 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.33178292 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.33178292 |
| 135 | positive regulation of interferon-beta production (GO:0032728) | 2.29806102 |
| 136 | regulation of interferon-alpha production (GO:0032647) | 2.29259774 |
| 137 | response to type I interferon (GO:0034340) | 2.28986053 |
| 138 | proteasome assembly (GO:0043248) | 2.28295898 |
| 139 | type I interferon signaling pathway (GO:0060337) | 2.28204614 |
| 140 | cellular response to type I interferon (GO:0071357) | 2.28204614 |
| 141 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.27545068 |
| 142 | cytokine production involved in immune response (GO:0002367) | 2.25878947 |
| 143 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.25411763 |
| 144 | neutrophil activation (GO:0042119) | 2.25024159 |
| 145 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.22855147 |
| 146 | NIK/NF-kappaB signaling (GO:0038061) | 2.22140091 |
| 147 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.22060103 |
| 148 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.22060103 |
| 149 | granulocyte activation (GO:0036230) | 2.22027022 |
| 150 | cellular protein complex disassembly (GO:0043624) | 2.21307252 |
| 151 | cellular response to interferon-beta (GO:0035458) | 2.21081012 |
| 152 | negative regulation of viral genome replication (GO:0045071) | 2.20905492 |
| 153 | lipoxygenase pathway (GO:0019372) | 2.18937844 |
| 154 | telomere maintenance via telomere lengthening (GO:0010833) | 2.18584161 |
| 155 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.18341479 |
| 156 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.17823895 |
| 157 | ribosome biogenesis (GO:0042254) | 2.16359607 |
| 158 | negative regulation by host of viral transcription (GO:0043922) | 2.15792334 |
| 159 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.15650374 |
| 160 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.11875508 |
| 161 | regulation of integrin activation (GO:0033623) | 2.11157755 |
| 162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.10912065 |
| 163 | endosome to melanosome transport (GO:0035646) | 2.09325862 |
| 164 | endosome to pigment granule transport (GO:0043485) | 2.09325862 |
| 165 | production of molecular mediator of immune response (GO:0002440) | 2.08484025 |
| 166 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.08171061 |
| 167 | leukotriene metabolic process (GO:0006691) | 2.08008141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.47061601 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.82935727 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64996797 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.61887894 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.60256845 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43906008 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41392940 |
| 8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11811963 |
| 9 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.10693320 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.09221027 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.06313203 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99545557 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98767001 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.93782786 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.92588525 |
| 16 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.92170566 |
| 17 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.92170566 |
| 18 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.92170566 |
| 19 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.91143692 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.91057942 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89287625 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84559169 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.82916948 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81572372 |
| 25 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.80209656 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77056159 |
| 27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.76305575 |
| 28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.75540614 |
| 29 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.73399809 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.72888395 |
| 31 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.69652163 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68882268 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68221772 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59431589 |
| 35 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.59125930 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.58224016 |
| 37 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.57824409 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57565615 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56894479 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56579110 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.56248737 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55815005 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.55679828 |
| 44 | * MAF_26560356_Chip-Seq_TH2_Human | 1.54476342 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52625452 |
| 46 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52109396 |
| 47 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.51732537 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50977320 |
| 49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.50871414 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50543004 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49490590 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46930232 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46351871 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44036563 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43158886 |
| 56 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.43091299 |
| 57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42884502 |
| 58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42249717 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42040732 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40943106 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40300263 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40230071 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39872058 |
| 64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.39195567 |
| 65 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.37345015 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34105871 |
| 67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32375690 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32341043 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31951047 |
| 70 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.31030674 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29905145 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29892059 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29088022 |
| 74 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28740397 |
| 75 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.27072202 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26838410 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26428353 |
| 78 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.25657926 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25287324 |
| 80 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25171766 |
| 81 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.23042219 |
| 82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22219212 |
| 83 | * MAF_26560356_Chip-Seq_TH1_Human | 1.21798262 |
| 84 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21713801 |
| 85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21701835 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20916616 |
| 87 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19009677 |
| 88 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.18016467 |
| 89 | MYB_26560356_Chip-Seq_TH2_Human | 1.17971654 |
| 90 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.17098783 |
| 91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.16139476 |
| 92 | * MYB_26560356_Chip-Seq_TH1_Human | 1.16079555 |
| 93 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14815858 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14230126 |
| 95 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14139423 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14124138 |
| 97 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13939137 |
| 98 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13621602 |
| 99 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13327771 |
| 100 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13178262 |
| 101 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13122628 |
| 102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11168193 |
| 103 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11149014 |
| 104 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.10656272 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08825376 |
| 106 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07720774 |
| 107 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07667266 |
| 108 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.07231617 |
| 109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07018785 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06747835 |
| 111 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06649896 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06533464 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06183813 |
| 114 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.04933037 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04446030 |
| 116 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.03417530 |
| 117 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03351089 |
| 118 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.03253596 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02995656 |
| 120 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02040016 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01685523 |
| 122 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00373944 |
| 123 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.00269871 |
| 124 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00075953 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00073253 |
| 126 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99628651 |
| 127 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99119593 |
| 128 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98619420 |
| 129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97901661 |
| 130 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96563684 |
| 131 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.95936956 |
| 132 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.95791234 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95408768 |
| 134 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95269118 |
| 135 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95003197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.20802569 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.84292469 |
| 3 | MP0008260_abnormal_autophagy | 2.80924557 |
| 4 | MP0009785_altered_susceptibility_to | 2.50077601 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.46523183 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.44653080 |
| 7 | MP0009278_abnormal_bone_marrow | 2.37523200 |
| 8 | MP0003436_decreased_susceptibility_to | 2.35414357 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.33898707 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.08266347 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.00204060 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 1.98114516 |
| 13 | MP0005025_abnormal_response_to | 1.96468280 |
| 14 | MP0000490_abnormal_crypts_of | 1.91556071 |
| 15 | MP0002396_abnormal_hematopoietic_system | 1.90920104 |
| 16 | MP0003724_increased_susceptibility_to | 1.90841278 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.88346411 |
| 18 | MP0000685_abnormal_immune_system | 1.86453120 |
| 19 | MP0002419_abnormal_innate_immunity | 1.85890890 |
| 20 | MP0003111_abnormal_nucleus_morphology | 1.85341413 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.84095507 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.84095507 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.83319467 |
| 24 | MP0005671_abnormal_response_to | 1.82892415 |
| 25 | MP0003077_abnormal_cell_cycle | 1.77310849 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.75958578 |
| 27 | MP0003075_altered_response_to | 1.71760688 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.70479098 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.68270692 |
| 30 | MP0001800_abnormal_humoral_immune | 1.66510955 |
| 31 | MP0010094_abnormal_chromosome_stability | 1.66151532 |
| 32 | MP0008057_abnormal_DNA_replication | 1.64012494 |
| 33 | MP0000343_altered_response_to | 1.61412591 |
| 34 | MP0005387_immune_system_phenotype | 1.61393179 |
| 35 | MP0001790_abnormal_immune_system | 1.61393179 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.59584148 |
| 37 | MP0001819_abnormal_immune_cell | 1.59280913 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.58371345 |
| 39 | MP0002723_abnormal_immune_serum | 1.57203802 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.56868150 |
| 41 | MP0005451_abnormal_body_composition | 1.53787300 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.53549880 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.52933518 |
| 44 | MP0003186_abnormal_redox_activity | 1.48687322 |
| 45 | MP0006082_CNS_inflammation | 1.46548986 |
| 46 | MP0008007_abnormal_cellular_replicative | 1.46224554 |
| 47 | MP0002405_respiratory_system_inflammati | 1.46180588 |
| 48 | MP0002398_abnormal_bone_marrow | 1.45282558 |
| 49 | MP0008058_abnormal_DNA_repair | 1.45111993 |
| 50 | MP0001853_heart_inflammation | 1.43116021 |
| 51 | MP0002722_abnormal_immune_system | 1.36725730 |
| 52 | MP0000858_altered_metastatic_potential | 1.36296186 |
| 53 | MP0003448_altered_tumor_morphology | 1.35388736 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.34898834 |
| 55 | MP0002254_reproductive_system_inflammat | 1.34792808 |
| 56 | MP0000716_abnormal_immune_system | 1.33991541 |
| 57 | MP0005083_abnormal_biliary_tract | 1.32165737 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.31649820 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.30995288 |
| 60 | MP0003828_pulmonary_edema | 1.28244302 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.26652237 |
| 62 | MP0002429_abnormal_blood_cell | 1.26037910 |
| 63 | MP0002006_tumorigenesis | 1.24181147 |
| 64 | MP0004947_skin_inflammation | 1.18079176 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.17475625 |
| 66 | MP0003567_abnormal_fetal_cardiomyocyte | 1.16644243 |
| 67 | MP0001873_stomach_inflammation | 1.16574261 |
| 68 | MP0005166_decreased_susceptibility_to | 1.16106174 |
| 69 | MP0003303_peritoneal_inflammation | 1.12917386 |
| 70 | MP0004883_abnormal_blood_vessel | 1.12383175 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.12304394 |
| 72 | MP0004381_abnormal_hair_follicle | 1.11196135 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.10051643 |
| 74 | MP0010307_abnormal_tumor_latency | 1.09131811 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.08625887 |
| 76 | MP0008004_abnormal_stomach_pH | 1.07276710 |
| 77 | MP0001851_eye_inflammation | 1.07223488 |
| 78 | MP0005164_abnormal_response_to | 1.06757869 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.06426496 |
| 80 | MP0003786_premature_aging | 1.05848608 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.05243463 |
| 82 | MP0009840_abnormal_foam_cell | 1.05073975 |
| 83 | MP0005023_abnormal_wound_healing | 1.04797148 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 1.04568115 |
| 85 | MP0009763_increased_sensitivity_to | 1.03311000 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.01527855 |
| 87 | MP0000371_diluted_coat_color | 1.00468670 |
| 88 | MP0008469_abnormal_protein_level | 1.00085137 |
| 89 | MP0000313_abnormal_cell_death | 0.99335074 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.95677444 |
| 91 | MP0001849_ear_inflammation | 0.95625656 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.95235964 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.94311535 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.94117676 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.92951088 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.91254137 |
| 97 | MP0000350_abnormal_cell_proliferation | 0.90805528 |
| 98 | MP0006054_spinal_hemorrhage | 0.90498563 |
| 99 | MP0005310_abnormal_salivary_gland | 0.89753411 |
| 100 | MP0008932_abnormal_embryonic_tissue | 0.89238751 |
| 101 | MP0002095_abnormal_skin_pigmentation | 0.86738509 |
| 102 | MP0004510_myositis | 0.85653648 |
| 103 | MP0003941_abnormal_skin_development | 0.84247773 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.81227473 |
| 105 | MP0002086_abnormal_extraembryonic_tissu | 0.81223490 |
| 106 | MP0001958_emphysema | 0.81180927 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.80517038 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.79902677 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.77953756 |
| 110 | MP0003795_abnormal_bone_structure | 0.77303987 |
| 111 | MP0004133_heterotaxia | 0.76566441 |
| 112 | MP0009764_decreased_sensitivity_to | 0.76428532 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.76250852 |
| 114 | MP0008873_increased_physiological_sensi | 0.74271158 |
| 115 | MP0003646_muscle_fatigue | 0.74184939 |
| 116 | MP0002132_abnormal_respiratory_system | 0.73991640 |
| 117 | MP0003279_aneurysm | 0.73914864 |
| 118 | MP0005380_embryogenesis_phenotype | 0.73356299 |
| 119 | MP0001672_abnormal_embryogenesis/_devel | 0.73356299 |
| 120 | MP0001542_abnormal_bone_strength | 0.73272407 |
| 121 | MP0002933_joint_inflammation | 0.72271042 |
| 122 | MP0005390_skeleton_phenotype | 0.72063858 |
| 123 | MP0004858_abnormal_nervous_system | 0.71496020 |
| 124 | MP0003984_embryonic_growth_retardation | 0.71481296 |
| 125 | MP0003136_yellow_coat_color | 0.71452892 |
| 126 | MP0006292_abnormal_olfactory_placode | 0.71353265 |
| 127 | MP0005076_abnormal_cell_differentiation | 0.70688756 |
| 128 | MP0003866_abnormal_defecation | 0.70312870 |
| 129 | MP0002653_abnormal_ependyma_morphology | 0.69823196 |
| 130 | MP0001663_abnormal_digestive_system | 0.69315174 |
| 131 | MP0002088_abnormal_embryonic_growth/wei | 0.69159660 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.68978008 |
| 133 | MP0000604_amyloidosis | 0.63249904 |
| 134 | MP0000358_abnormal_cell_content/ | 0.60096957 |
| 135 | MP0005165_increased_susceptibility_to | 0.58045467 |
| 136 | MP0003011_delayed_dark_adaptation | 0.56446659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.81703750 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.41286032 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.01033648 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.91455387 |
| 5 | Reticulocytopenia (HP:0001896) | 3.58516551 |
| 6 | Myositis (HP:0100614) | 3.46696531 |
| 7 | Hepatosplenomegaly (HP:0001433) | 3.27368786 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 3.18669203 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17308372 |
| 10 | Episodic fever (HP:0001954) | 3.05263183 |
| 11 | Purpura (HP:0000979) | 2.97921435 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 2.97575079 |
| 13 | Increased serum ferritin (HP:0003281) | 2.97070829 |
| 14 | Encephalitis (HP:0002383) | 2.93606665 |
| 15 | Amyloidosis (HP:0011034) | 2.92750449 |
| 16 | Loss of speech (HP:0002371) | 2.91923313 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.87191480 |
| 18 | Increased IgE level (HP:0003212) | 2.82115423 |
| 19 | Hypochromic microcytic anemia (HP:0004840) | 2.80901006 |
| 20 | Orchitis (HP:0100796) | 2.77753227 |
| 21 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.74149903 |
| 22 | Recurrent fungal infections (HP:0002841) | 2.72712800 |
| 23 | Abnormal number of erythroid precursors (HP:0012131) | 2.71150366 |
| 24 | Thrombocytosis (HP:0001894) | 2.70470107 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 2.67685635 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65163323 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65163323 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63926044 |
| 29 | Pustule (HP:0200039) | 2.63700710 |
| 30 | Agnosia (HP:0010524) | 2.63623424 |
| 31 | Chromsome breakage (HP:0040012) | 2.62648610 |
| 32 | Aplastic anemia (HP:0001915) | 2.60121668 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 2.60023236 |
| 34 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.57090256 |
| 35 | Petechiae (HP:0000967) | 2.56516503 |
| 36 | IgM deficiency (HP:0002850) | 2.56388584 |
| 37 | Abnormality of iron homeostasis (HP:0011031) | 2.54467413 |
| 38 | Epistaxis (HP:0000421) | 2.52662585 |
| 39 | Recurrent viral infections (HP:0004429) | 2.50322867 |
| 40 | Chest pain (HP:0100749) | 2.43251117 |
| 41 | Gingivitis (HP:0000230) | 2.42405918 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.41316851 |
| 43 | Nausea (HP:0002018) | 2.41272689 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.38695052 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.38412254 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37749725 |
| 47 | Obstructive lung disease (HP:0006536) | 2.37749725 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.35611055 |
| 49 | Gingival bleeding (HP:0000225) | 2.34341694 |
| 50 | Poikiloderma (HP:0001029) | 2.29420623 |
| 51 | Progressive neurologic deterioration (HP:0002344) | 2.28176038 |
| 52 | Hypertensive crisis (HP:0100735) | 2.27650755 |
| 53 | Type I transferrin isoform profile (HP:0003642) | 2.26759530 |
| 54 | Hypochromic anemia (HP:0001931) | 2.26641304 |
| 55 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.25253196 |
| 56 | Amaurosis fugax (HP:0100576) | 2.21998251 |
| 57 | Optic neuritis (HP:0100653) | 2.20713423 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.20713423 |
| 59 | Granulocytopenia (HP:0001913) | 2.20597880 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.19351062 |
| 61 | Poor head control (HP:0002421) | 2.19090362 |
| 62 | Hemoptysis (HP:0002105) | 2.15631877 |
| 63 | Increased IgM level (HP:0003496) | 2.15597205 |
| 64 | Pallor (HP:0000980) | 2.14942267 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.14785394 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.14685650 |
| 67 | Selective tooth agenesis (HP:0001592) | 2.14014943 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 2.13553274 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.11259871 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.10926723 |
| 71 | Eosinophilia (HP:0001880) | 2.09380375 |
| 72 | Recurrent skin infections (HP:0001581) | 2.08596921 |
| 73 | Leukocytosis (HP:0001974) | 2.08231678 |
| 74 | Carpal bone hypoplasia (HP:0001498) | 2.07798015 |
| 75 | 11 pairs of ribs (HP:0000878) | 2.06593384 |
| 76 | Premature loss of primary teeth (HP:0006323) | 2.03855791 |
| 77 | Acute hepatic failure (HP:0006554) | 2.02187584 |
| 78 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.00991860 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00955075 |
| 80 | Microcytic anemia (HP:0001935) | 2.00427227 |
| 81 | Urticaria (HP:0001025) | 1.99256858 |
| 82 | Abnormality of T cells (HP:0002843) | 1.98962212 |
| 83 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98760546 |
| 84 | Distal lower limb muscle weakness (HP:0009053) | 1.98040693 |
| 85 | Myelodysplasia (HP:0002863) | 1.97035965 |
| 86 | Multiple enchondromatosis (HP:0005701) | 1.97015274 |
| 87 | Arterial thrombosis (HP:0004420) | 1.96265982 |
| 88 | Abnormal gallbladder physiology (HP:0012438) | 1.95686328 |
| 89 | Cholecystitis (HP:0001082) | 1.95686328 |
| 90 | Cellulitis (HP:0100658) | 1.95596303 |
| 91 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.95455141 |
| 92 | Lymphopenia (HP:0001888) | 1.93734349 |
| 93 | Basal ganglia calcification (HP:0002135) | 1.91799385 |
| 94 | Abnormal platelet volume (HP:0011876) | 1.91703807 |
| 95 | Rough bone trabeculation (HP:0100670) | 1.91472312 |
| 96 | Bone marrow hypocellularity (HP:0005528) | 1.91205980 |
| 97 | Spinal muscular atrophy (HP:0007269) | 1.90993039 |
| 98 | Osteomyelitis (HP:0002754) | 1.90890020 |
| 99 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.87116828 |
| 100 | Meningitis (HP:0001287) | 1.85855280 |
| 101 | Albinism (HP:0001022) | 1.84963136 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 1.84537887 |
| 103 | Disinhibition (HP:0000734) | 1.83771265 |
| 104 | Absent thumb (HP:0009777) | 1.83172840 |
| 105 | Vasculitis (HP:0002633) | 1.83127131 |
| 106 | Lymphoma (HP:0002665) | 1.83041585 |
| 107 | Metaphyseal cupping (HP:0003021) | 1.81955849 |
| 108 | Abnormality of chromosome stability (HP:0003220) | 1.81401103 |
| 109 | Nasal polyposis (HP:0100582) | 1.80881022 |
| 110 | Abnormality of eosinophils (HP:0001879) | 1.80270292 |
| 111 | Sepsis (HP:0100806) | 1.79451306 |
| 112 | Gangrene (HP:0100758) | 1.79384593 |
| 113 | Splenomegaly (HP:0001744) | 1.79337949 |
| 114 | Severe visual impairment (HP:0001141) | 1.77901730 |
| 115 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.77806332 |
| 116 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.77806332 |
| 117 | Pulmonary embolism (HP:0002204) | 1.77197090 |
| 118 | Anorexia (HP:0002039) | 1.76454622 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 1.75901173 |
| 120 | Respiratory difficulties (HP:0002880) | 1.75785004 |
| 121 | Periodontitis (HP:0000704) | 1.75460294 |
| 122 | Skin rash (HP:0000988) | 1.75396019 |
| 123 | Abnormality of the anterior horn cell (HP:0006802) | 1.74788784 |
| 124 | Degeneration of anterior horn cells (HP:0002398) | 1.74788784 |
| 125 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.74264909 |
| 126 | Cervical subluxation (HP:0003308) | 1.72912583 |
| 127 | Prostate neoplasm (HP:0100787) | 1.72395176 |
| 128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71437112 |
| 129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71437112 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71437112 |
| 131 | Proximal tubulopathy (HP:0000114) | 1.70546719 |
| 132 | Basal cell carcinoma (HP:0002671) | 1.69955389 |
| 133 | Stomatitis (HP:0010280) | 1.68940710 |
| 134 | Generalized aminoaciduria (HP:0002909) | 1.67772392 |
| 135 | Colon cancer (HP:0003003) | 1.66831042 |
| 136 | Increased cerebral lipofuscin (HP:0011813) | 1.66154434 |
| 137 | Meckel diverticulum (HP:0002245) | 1.65551309 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.64426310 |
| 139 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.64426310 |
| 140 | Chronic otitis media (HP:0000389) | 1.64161341 |
| 141 | Prolonged bleeding time (HP:0003010) | 1.64042704 |
| 142 | Tracheoesophageal fistula (HP:0002575) | 1.63939406 |
| 143 | Entropion (HP:0000621) | 1.63088634 |
| 144 | Abnormality of B cell number (HP:0010975) | 1.62024732 |
| 145 | B lymphocytopenia (HP:0010976) | 1.62024732 |
| 146 | Skin ulcer (HP:0200042) | 1.61905417 |
| 147 | Abnormality of the ileum (HP:0001549) | 1.61720236 |
| 148 | Dysostosis multiplex (HP:0000943) | 1.60827316 |
| 149 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.59998600 |
| 150 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59378688 |
| 151 | Abnormal glycosylation (HP:0012345) | 1.59378688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 2.96902307 |
| 2 | NME2 | 2.86858501 |
| 3 | TESK2 | 2.52068221 |
| 4 | MAP4K1 | 2.46381191 |
| 5 | IRAK4 | 2.39411164 |
| 6 | TNK2 | 2.31407915 |
| 7 | VRK2 | 2.19092599 |
| 8 | KIT | 2.17931278 |
| 9 | BLK | 2.14576327 |
| 10 | WEE1 | 2.14252924 |
| 11 | EPHA2 | 2.08532114 |
| 12 | MAP2K3 | 2.08027722 |
| 13 | FES | 2.02427837 |
| 14 | FLT3 | 1.97036602 |
| 15 | ZAP70 | 1.96430986 |
| 16 | TAOK1 | 1.95121658 |
| 17 | TXK | 1.81718369 |
| 18 | TYK2 | 1.76961734 |
| 19 | FGR | 1.72452805 |
| 20 | TAOK2 | 1.71030911 |
| 21 | MAP3K14 | 1.66918807 |
| 22 | TBK1 | 1.65459220 |
| 23 | BUB1 | 1.62195882 |
| 24 | ERN1 | 1.59570063 |
| 25 | TGFBR2 | 1.57912052 |
| 26 | CDK12 | 1.53281362 |
| 27 | JAK3 | 1.52788983 |
| 28 | MATK | 1.52647411 |
| 29 | MAPKAPK3 | 1.48276350 |
| 30 | IKBKB | 1.46263669 |
| 31 | PIM2 | 1.45427252 |
| 32 | CSF1R | 1.42022789 |
| 33 | PIM1 | 1.41714583 |
| 34 | STK10 | 1.41407036 |
| 35 | RPS6KB2 | 1.39861788 |
| 36 | TEC | 1.39261113 |
| 37 | PAK4 | 1.35070069 |
| 38 | BTK | 1.34937943 |
| 39 | CDK7 | 1.34402264 |
| 40 | TGFBR1 | 1.32572158 |
| 41 | STK4 | 1.32174126 |
| 42 | ZAK | 1.31729261 |
| 43 | KDR | 1.29219374 |
| 44 | TESK1 | 1.28566181 |
| 45 | NEK2 | 1.26779757 |
| 46 | PRPF4B | 1.25189844 |
| 47 | TTK | 1.24969065 |
| 48 | BRSK2 | 1.22171761 |
| 49 | SMG1 | 1.19111742 |
| 50 | STK16 | 1.18764998 |
| 51 | TIE1 | 1.16231617 |
| 52 | CLK1 | 1.15854348 |
| 53 | RPS6KA4 | 1.13488191 |
| 54 | CDK19 | 1.12053554 |
| 55 | IKBKE | 1.10151151 |
| 56 | MAP3K1 | 1.07947837 |
| 57 | ARAF | 1.05855377 |
| 58 | SIK3 | 1.05752896 |
| 59 | PLK4 | 1.04470117 |
| 60 | LRRK2 | 1.01995122 |
| 61 | SRPK1 | 1.01020969 |
| 62 | MAP3K11 | 1.00453500 |
| 63 | DYRK3 | 0.97888458 |
| 64 | ACVR1B | 0.97717873 |
| 65 | CSK | 0.96443882 |
| 66 | EIF2AK3 | 0.95903601 |
| 67 | EIF2AK1 | 0.93620551 |
| 68 | EEF2K | 0.93510581 |
| 69 | TTN | 0.93339752 |
| 70 | YES1 | 0.92023666 |
| 71 | ATR | 0.91146588 |
| 72 | CDK4 | 0.90876468 |
| 73 | NEK9 | 0.90792339 |
| 74 | MAP3K6 | 0.88308698 |
| 75 | PTK6 | 0.87141833 |
| 76 | CHUK | 0.86546406 |
| 77 | NEK1 | 0.86482598 |
| 78 | PASK | 0.85720492 |
| 79 | HCK | 0.81988428 |
| 80 | BMX | 0.79417136 |
| 81 | JAK2 | 0.77524952 |
| 82 | MARK3 | 0.77434688 |
| 83 | ABL2 | 0.76830958 |
| 84 | STK3 | 0.76475658 |
| 85 | PLK1 | 0.76237384 |
| 86 | MAP2K6 | 0.75187872 |
| 87 | AURKB | 0.75101626 |
| 88 | PRKD2 | 0.74986861 |
| 89 | LCK | 0.74934843 |
| 90 | CDC7 | 0.74756193 |
| 91 | LYN | 0.72321237 |
| 92 | GRK7 | 0.72181785 |
| 93 | PKN2 | 0.71866276 |
| 94 | TLK1 | 0.71667958 |
| 95 | VRK1 | 0.70539486 |
| 96 | SYK | 0.70416187 |
| 97 | NLK | 0.70211776 |
| 98 | IRAK2 | 0.69219083 |
| 99 | NME1 | 0.68993928 |
| 100 | MAP3K8 | 0.67356067 |
| 101 | PRKG2 | 0.66938848 |
| 102 | PAK1 | 0.66781803 |
| 103 | TAOK3 | 0.66610562 |
| 104 | RPS6KL1 | 0.65992970 |
| 105 | RPS6KC1 | 0.65992970 |
| 106 | RPS6KA6 | 0.63625277 |
| 107 | EIF2AK2 | 0.63460339 |
| 108 | PBK | 0.62762084 |
| 109 | MAP3K5 | 0.61022676 |
| 110 | ITK | 0.59963028 |
| 111 | SCYL2 | 0.59533088 |
| 112 | RIPK1 | 0.57388946 |
| 113 | MYLK | 0.57306279 |
| 114 | MAP3K3 | 0.57268669 |
| 115 | EPHB1 | 0.56005840 |
| 116 | BCKDK | 0.53697496 |
| 117 | MAP3K13 | 0.53346346 |
| 118 | PTK2B | 0.53008860 |
| 119 | IRAK1 | 0.52472302 |
| 120 | TRPM7 | 0.52147877 |
| 121 | SIK1 | 0.49200291 |
| 122 | RIPK4 | 0.48541266 |
| 123 | KSR2 | 0.47664735 |
| 124 | JAK1 | 0.46515165 |
| 125 | TRIB3 | 0.45372828 |
| 126 | PDPK1 | 0.44932943 |
| 127 | GRK6 | 0.44678362 |
| 128 | PDK2 | 0.44615240 |
| 129 | MST4 | 0.44354423 |
| 130 | AKT3 | 0.43939583 |
| 131 | BMPR2 | 0.43891060 |
| 132 | MAPKAPK2 | 0.43462977 |
| 133 | MKNK2 | 0.43174387 |
| 134 | FYN | 0.41058316 |
| 135 | CHEK2 | 0.40872644 |
| 136 | MOS | 0.40003690 |
| 137 | LIMK1 | 0.39258881 |
| 138 | PRKCD | 0.38802409 |
| 139 | PDK1 | 0.38656011 |
| 140 | DAPK1 | 0.38021842 |
| 141 | RAF1 | 0.37922220 |
| 142 | PRKCQ | 0.33736412 |
| 143 | MARK2 | 0.29581563 |
| 144 | CDC42BPA | 0.26069724 |
| 145 | BRAF | 0.25701388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.18793958 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.00661373 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.79387242 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.30283201 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16333722 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.15299805 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.14829667 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.12066643 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.02944487 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.97380366 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 1.91568866 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.87644651 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78778486 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.65930291 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.55539500 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55096644 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55074157 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.53233342 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52619000 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50559204 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.50452290 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45125223 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.43319586 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.40402312 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39685490 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39651656 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39232353 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.36584588 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36040743 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35167126 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33716277 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.33049660 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32703988 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30824958 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25403621 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.24258125 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21770394 |
| 38 | Cell cycle_Homo sapiens_hsa04110 | 1.19567497 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.17808491 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17487110 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.16192224 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15895619 |
| 43 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15576345 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.14747006 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.13275514 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.12993796 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.12475306 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.12195253 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09551035 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05488750 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03672187 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99275253 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98321968 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96997820 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 0.96925449 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96865924 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95195168 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.94965832 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93722465 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90829424 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90166388 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89006956 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85685160 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84211064 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.83787146 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83132874 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82551071 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81243059 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81185178 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80297342 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79549654 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79431210 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.79290408 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78601705 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76562112 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75073682 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73549407 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73338845 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71189793 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.70361358 |
| 81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67031205 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66212166 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65740369 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65145810 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64285728 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62100433 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.61980525 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60434621 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59987805 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59792874 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.59367981 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58704993 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56706959 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53974081 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52386436 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51059112 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.49412918 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49000925 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48701045 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48230095 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47335476 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46814957 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46803201 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45310107 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44861309 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43144285 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41816573 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.41189088 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40926632 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40802263 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40076991 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38416128 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.37933753 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37870865 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37524638 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37254413 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37012993 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.34931249 |
| 119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30765675 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29344471 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.28978109 |

